Clinical trial
Depiction of Prostate Cancer Treatment Alternatives in Greece
NCT00733213 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Depiction of Prostate Cancer Treatment Alternatives in Greece
- Lead sponsor
- AstraZeneca
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2008
- Completion date
- March 31, 2009
- Enrollment
- 310 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
locally advanced or metastatic prostate cancer.